000			02025 a2200553 4500
005			20250517140152.0
264		0	_c20180118
008			201801s 0 0 eng d
022			_a1592-8721
024	7		_a10.3324/haematol.2016.152496 _2doi
040			_aNLM _beng _cNLM
100	1		_aVerhoef, Gregor
245	0	0	_aAssociation between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP _h[electronic resource]
260			_bHaematologica _c05 2017
300			_a895-902 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLymphoma, Mantle-Cell _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aRemission Induction
650	0	4	_aRituximab _xadministration & dosage
650	0	4	_aVincristine _xadministration & dosage
700	1		_aRobak, Tadeusz
700	1		_aHuang, Huiqiang
700	1		_aPylypenko, Halyna
700	1		_aSiritanaratkul, Noppadol
700	1		_aPereira, Juliana
700	1		_aDrach, Johannes
700	1		_aMayer, Jiri
700	1		_aOkamoto, Rumiko
700	1		_aPei, Lixia
700	1		_aRooney, Brendan
700	1		_aCakana, Andrew
700	1		_avan de Velde, Helgi
700	1		_aCavalli, Franco
773	0		_tHaematologica _gvol. 102 _gno. 5 _gp. 895-902
856	4	0	_uhttps://doi.org/10.3324/haematol.2016.152496 _zAvailable from publisher's website
999			_c26867388 _d26867388